SCHEMBL493413

SCHEMBL493413

CN(C)C(c1ccccc1)C1CCC(NC(=O)COc2ccccc2N(C)S(=O)(=O)c2ccc(Cl)c(Cl)c2)CC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
POLB P06746 2/20 0.42
MEN1 O00255 1/20 0.42
GAA P10253 1/20 0.42
ALDH1A1 P00352 3/20 0.42
ALPL P05186 1/20 0.40
ALPI P09923 1/20 0.40
ALPG P10696 1/20 0.40
PSEN1 P49768 3/20 0.39
PSEN2 P49810 3/20 0.39
SPPL2A Q8TCT8 3/20 0.39
APH1B Q8WW43 3/20 0.39
NCSTN Q92542 3/20 0.39
APH1A Q96BI3 3/20 0.39
PSENEN Q9NZ42 3/20 0.39
HPGD P15428 1/20 0.39
RAB9A P51151 2/20 0.38
MAPK1 P28482 1/20 0.38
NPC1 O15118 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL644212 0.83 HTT (0.45) KMT2ASMN1; SMN2MEN1GAAALDH1A1
SCHEMBL3666768 0.82 KMT2A (0.43) KMT2ASMN1; SMN2POLBMEN1GAA
SCHEMBL492539 0.80 KMT2A (0.43) KMT2ASMN1; SMN2POLBMEN1GAA
SCHEMBL644813 0.79 L3MBTL1 (0.41) KMT2ASMN1; SMN2POLBMEN1ALDH1A1
SCHEMBL493188 0.77 SPPL2A (0.36) KMT2ASMN1; SMN2POLBMEN1GAA
SCHEMBL493681 0.77 KMT2A (0.50) KMT2ASMN1; SMN2POLBALDH1A1ALPL
SCHEMBL644136 0.77 L3MBTL1 (0.41) KMT2ASMN1; SMN2MEN1ALDH1A1ALPL
SCHEMBL643252 0.76 KMT2A (0.42) KMT2ASMN1; SMN2MEN1GAAALDH1A1
SCHEMBL643403 0.76 SPPL2A (0.39) KMT2ASMN1; SMN2MEN1GAAPSEN1
SCHEMBL492745 0.75 KMT2A (0.41) KMT2ASMN1; SMN2POLBMEN1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8106055-B2 Substituted amide compounds GRUENENTHAL GMBH (DE) 2012-01-31 US claimed
US-20080306084-A1 Substituted Amide Compounds GRUENENTHAL GMBH (DE) 2008-12-11 US claimed
US-8106055-B2 Substituted amide compounds GRUENENTHAL GMBH (DE) 2012-01-31 US disclosed
US-20080306084-A1 Substituted Amide Compounds GRUENENTHAL GMBH (DE) 2008-12-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080306084-A1 Substituted Amide Compounds OPRK1, NAA50, ACMSD KMT2A 1749/4885SMN1; SMN2 1729/4885POLB 2120/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.